Lexeo Therapeutics (LXEO) Times Interest Earned (2022 - 2026)
Lexeo Therapeutics recorded quarterly Times Interest Earned of -$1313.7 in Q1 2026, down 13.66% quarter-over-quarter from -$1155.8 in Q4 2025, and down 8.81% year-over-year from -$1440.7 in Q1 2025.
Lexeo Therapeutics' Times Interest Earned history runs 5 years deep, the most recent figure standing at -$1313.7 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 8.81% year-over-year to -$1313.7; the TTM figure through Mar 2026 stood at -$1164.1 (down 377.81% YoY), while the FY2025 annual figure was -$1150.1, down 662.23% from the prior year.
- Times Interest Earned came in at -$1313.7 for Q1 2026 at Lexeo Therapeutics, down from -$1155.8 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $1923.8 in Q4 2024 to a low of -$1313.7 in Q1 2026.
- A 5-year average of -$559.42 and a median of -$629.49 in 2024 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned soared 742.37% in 2024 and slumped 160.08% in 2025, its largest moves.
- Lexeo Therapeutics' Times Interest Earned stood at -$281.43 in 2022, then retreated by 6.42% to -$299.48 in 2023, then soared by 742.37% to $1923.8 in 2024, then plunged by 160.08% to -$1155.8 in 2025, then dropped by 13.66% to -$1313.7 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$1313.7, -$1155.8, and -$984.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - | -1,313.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,313.71 |
| Dec 31, 2025 | -1,155.80 |
| Sep 30, 2025 | -984.00 |
| Jun 30, 2025 | -1,227.52 |
| Mar 31, 2025 | -1,207.32 |
| Dec 31, 2024 | 1,923.77 |
| Sep 30, 2024 | -901.23 |
| Jun 30, 2024 | -672.86 |
| Mar 31, 2024 | -629.49 |
| Dec 31, 2023 | -299.48 |
| Sep 30, 2023 | -389.87 |
| Jun 30, 2023 | -263.68 |
| Mar 31, 2023 | -385.80 |
| Dec 31, 2022 | -281.43 |
| Sep 30, 2022 | -602.83 |